You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 2776 to 2800 of about 5953
Next 25
06/18/2011
3rd Annual Brain Cancer Symposium Saturday, June 25, 2011 9:00-3:30 pm
06/16/2011
Concomitant temozolomide and radiotherapy versus radiotherapy alone for treatment of newly diagnosed glioblastoma multiforme.
Specialised Therapeutics to License Brain Tumour Visualisation Drug Gliolan in Australia & NZ
Engineering the brain tumor microenvironment enhances the efficacy of dendritic cells` vaccination: implications for clinical trials design.
Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study .
Phase 2 study of carboplatin, irinotecan, and bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy.
Intracranial hemorrhage in patients with cancer treated with bevacizumab: the Memorial Sloan-Kettering experience.
Tumor treating fields: concept, evidence and future.
Voices Against Brain Cancer`s Annual Gala in NY is tonight!
06/14/2011
"Navigating the Insurance Maze " - a free seminar for individuals and families coping with all types of brain tumors
06/13/2011
Stemline Therapeutics Announces Oral Presentation of Positive Phase I/II Trial Results with Novel Brain Cancer Vaccine at ASCO
06/10/2011
FDA Gives Green Light to Simultaneous PET/MRI System
06/07/2011
Tocagen`s First-in-Human Clinical Trial of Toca 511 Enrolling Patients with High Grade Glioma
Treatment with OPAXIO® (Paclitaxel Poliglumex),Temozolomide and Radiotherapy Results in Encouraging Progression Free Survival in Patients With High Grade Malignant Brain Tumor
06/06/2011
Antifungal Drug Delays Need For Chemo In Advanced Prostate Cancer
New technique hopeful option for treating cancer
New Data From Phase 2 Brain Cancer Study With Prophage Series G-200 (HSPPC-96) Shows Improved Overall Survival
06/05/2011
Free summer program for kids and teens impacted by brain tumors
06/04/2011
Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times
NICO Corporation Receives Health Canada Approval for Brain Tumor Removal Tool
06/02/2011
Bevacizumab (Avastin)-induced hypertension: pathogenesis and management.
Save the date: Diagnosis Brain Tumor: You are not alone IV - a conference for patients, families and friends in NJ on October 29, 2011!
05/31/2011
IBTA E NEWS MAY 2011
YM BioSciences closes nimotuzumab trials in North America PBR Staff Writer